Adora2b drives the formation of an immunosuppressive microenvironment in gastric cancer by regulating the functions of CD8+ T cells, regulatory T cells (Tregs), and tumor-associated macrophages (TAMs) through distinct downstream pathways (26, 93, 98). Here, ADORA2B is linked to gastric cancer.